Cargando…
Plasma Interleukin-6 Predicts Clinical Decline After Completion of Dexamethasone Therapy in Severe COVID-19
To identify and characterize clinical decline after completion of dexamethasone in severe COVID-19 and determine whether interleukin (IL)-6 and other inflammatory biomarkers predict the occurrence of clinical decline. DESIGN: Prospective observational cohort. SETTING: ICUs in three University of Was...
Autores principales: | Mabrey, F. Linzee, Bhatraju, Pavan K., Morrell, Eric D., Zelnick, Leila R., Sathe, Neha A., O’Connor, Nicholas G., Mikacenic, Carmen, Martin, Thomas R., Liles, W. Conrad, Wurfel, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760624/ https://www.ncbi.nlm.nih.gov/pubmed/36567786 http://dx.doi.org/10.1097/CCE.0000000000000813 |
Ejemplares similares
-
Presence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus-2 on Admission Is Associated With Decreased Mortality in COVID-19 Critical Illness
por: Mabrey, F. Linzee, et al.
Publicado: (2022) -
Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019
por: Mabrey, F. Linzee, et al.
Publicado: (2021) -
Identification of persistent and resolving subphenotypes of acute hypoxemic respiratory failure in two independent cohorts
por: Sathe, Neha A., et al.
Publicado: (2021) -
Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach
por: Sathe, Neha A., et al.
Publicado: (2023) -
TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
por: Mabrey, F. Linzee, et al.
Publicado: (2021)